British court rules drug data must be shared
Wall Street Journal (subscription required), May 2, 2008
The Court of Appeal in London has ruled the National Institute for Health and Clinical Excellence must reveal how it calculated that certain Alzheimer's drugs weren't cost-effective for some patients. The court said the institute had acted unfairly by not fully disclosing how it evaluated the drugs, and the move highlights a rising tension between cash-strapped entities that pay for healthcare against patients and drug companies.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
- ED Physicians Key to Half of Hospital Admissions
- Quiet ORs Better for Patient Safety
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- CMS Releases Hospital Pricing Data
